Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Free Cash Flow: 2020-2024

Historic Free Cash Flow for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to -$30.3 million.

  • Oncology Institute's Free Cash Flow fell 118386.57% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.7 million, marking a year-over-year increase of 2611.7%. This contributed to the annual value of -$30.3 million for FY2024, which is 2581.82% up from last year.
  • Per Oncology Institute's latest filing, its Free Cash Flow stood at -$30.3 million for FY2024, which was up 2581.82% from -$40.9 million recorded in FY2023.
  • In the past 5 years, Oncology Institute's Free Cash Flow registered a high of -$686000.0 during FY2020, and its lowest value of -$67.3 million during FY2022.
  • In the last 5 years, Oncology Institute's Free Cash Flow had a median value of -$35.5 million in 2021 and averaged -$34.9 million.
  • Per our database at Business Quant, Oncology Institute's Free Cash Flow tumbled by 507886.3% in 2021 and then surged by 3924.05% in 2023.
  • Oncology Institute's Free Cash Flow (Annual) stood at -$686000.0 in 2020, then tumbled by 5078.86% to -$35.5 million in 2021, then tumbled by 89.39% to -$67.3 million in 2022, then skyrocketed by 39.24% to -$40.9 million in 2023, then increased by 25.82% to -$30.3 million in 2024.
  • Its Free Cash Flow stands at -$30.3 million for FY2024, versus -$40.9 million for FY2023 and -$67.3 million for FY2022.